Citation Impact
Citing Papers
Comparison of Two Fluid-Management Strategies in Acute Lung Injury
2006 Standout
Requirement of bic/microRNA-155 for Normal Immune Function
2007 StandoutScience
Long-Term Ozone Exposure and Mortality
2009 Standout
Incidence and prevalence of idiopathic pulmonary fibrosis in US adults 18–64 years old
2016
ATLa, an Aspirin-Triggered Lipoxin A4 Synthetic Analog, Prevents the Inflammatory and Fibrotic Effects of Bleomycin-Induced Pulmonary Fibrosis
2009
Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysema
2011
The Increasing Secondary Care Burden of Idiopathic Pulmonary Fibrosis
2013
Increasing Global Mortality from Idiopathic Pulmonary Fibrosis in the Twenty-First Century
2014
Effects of Living at Higher Altitudes on Mortality: A Narrative Review
2014
Cardiovascular Risk Factors in Snorers
1992
Idiopathic Pulmonary Fibrosis: Current Concepts
1998
The Collective Dynamics of Smoking in a Large Social Network
2008 Standout
Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508delCFTR
2015 Standout
Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
2010 Standout
Case-Control Study of Idiopathic Pulmonary Fibrosis and Environmental Exposures
1998
Incidence and prevalence of cryptogenic fibrosing alveolitis in a Norwegian community
2003
Use of Spirometry for Case Finding, Diagnosis, and Management of Chronic Obstructive Pulmonary Disease (COPD): Evidence Report/Technology Assessment, Number 121
2005
A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
2014 Standout
HLA-DRB1*1101: A Significant Risk Factor for Sarcoidosis in Blacks and Whites
2003
The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease
2004 Standout
Pro-resolving lipid mediators are leads for resolution physiology
2014 StandoutNature
Snoring in a Hispanic-American population. Risk factors and association with hypertension and other morbidity
1990
Snoring and risk of cardiovascular disease in women
2000
Wound repair and regeneration
2008 StandoutNature
Lifetime environmental tobacco smoke exposure and the risk of chronic obstructive pulmonary disease
2005
Pulmonary fibrosis: pathogenesis, etiology and regulation
2009 Standout
Mechanisms of Chromium Carcinogenicity and Toxicity
1993
Airway obstruction in never smokers: Results from the Third National Health and Nutrition Examination Survey
2005
Results of a Home-Based Environmental Intervention among Urban Children with Asthma
2004 Standout
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Contemporary Management of Chronic Obstructive Pulmonary Disease
2003
Worldwide epidemiology of chronic obstructive pulmonary disease
1999
Association of Sleep-Disordered Breathing, Sleep Apnea, and Hypertension in a Large Community-Based Study
2000 Standout
Mortality from Pulmonary Fibrosis Increased in the United States from 1992 to 2003
2007
The Burden of Respiratory Syncytial Virus Infection in Young Children
2009 Standout
Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001–11
2014
Ca2+/Calmodulin Kinase-dependent Activation of Hypoxia Inducible Factor 1 Transcriptional Activity in Cells Subjected to Intermittent Hypoxia
2004 StandoutNobel
Nonresolving Inflammation
2010 Standout
Prospective Study of the Association between Sleep-Disordered Breathing and Hypertension
2000 Standout
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
Nationwide prevalence of sporadic and familial idiopathic pulmonary fibrosis: evidence of founder effect among multiplex families in Finland
2002
Cyclophosphamide in the Treatment of Idiopathic Pulmonary Fibrosis
2000
Pulmonary fibrosis deaths in the United States, 1979-1991. An analysis of multiple-cause mortality data.
1996
Smokers' behaviour and exposure according to cigarette yield and smoking experience
1995
Underuse of spirometry by general practitioners for the diagnosis of COPD in Italy
2005
The Diagnosis, Assessment and Treatment of Diffuse Parenchymal Lung Disease in Adults
1999
The development and validation of the King's Brief Interstitial Lung Disease (K-BILD) health status questionnaire
2012
The role of CXC chemokines in pulmonary fibrosis
2007
Alpha1-antitrypsin phenotypes in patients with cryptogenic fibrosing alveolitis: a case-control study
1997
Mortality in COPD: role of comorbidities
2006
The Occurrence of Sleep-Disordered Breathing among Middle-Aged Adults
1993 Standout
A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
2006 Standout
EMT: 2016
2016 Standout
Carbon Monoxide Poisoning
1998 Standout
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
2015 Standout
Prevalence of chronic bronchitis among US Hispanics from the Hispanic Health and Nutrition Examination Survey, 1982-84.
1990
Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis
2004 Standout
Idiopathic Pulmonary Fibrosis
2001 Standout
Prevalence of sleep apnoea syndrome in the Spanish adult population
1997
Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review
2015
Understanding the Intersections between Metabolism and Cancer Biology
2017 Standout
Race and gender differences in acute respiratory distress syndrome deaths in the United States: An analysis of multiple-cause mortality data (1979–1996)*
2002
Epidemiology and costs of chronic obstructive pulmonary disease
2005
REGISTRATION OF INTERSTITIAL LUNG DISEASES BY 20 CENTRES OF RESPIRATORY MEDICINE IN FLANDERS
2001
Pulmonary Rehabilitation for Moderate COPD (GOLD 2) –Does it Have an Effect?
2011
Occupational exposure to metal or wood dust and aetiology of cryptogenic fibrosing alveolitis
1996
Adenovirus-mediated HIF-1α gene transfer promotes repair of mouse airway allograft microvasculature and attenuates chronic rejection
2011 StandoutNobel
Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
2007 Standout
Evaluation of the Short-Form 36-Item Questionnaire to Measure Health-Related Quality of Life in Patients With Idiopathic Pulmonary Fibrosis
2000
The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary Disease
2004 Standout
TRPA1 Mediates the Inflammatory Actions of Environmental Irritants and Proalgesic Agents
2006 StandoutNobel
A Short-Term Comparison of Fluticasone Propionate/Salmeterol with Ipratropium Bromide/Albuterol for the Treatment of COPD
2004
Sarcoidosis
2007 Standout
Indoor residential chemical emissions as risk factors for respiratory and allergic effects in children: a review
2007
Selection of Ecologic Covariates in the American Cancer Society Study
2003
Patterns of cigarette smoking among Hispanics in the United States: results from HHANES 1982-84.
1990
Autoimmunity and interstitial lung disease
2005
Incidence and Prevalence of Idiopathic Pulmonary Fibrosis
2006 Standout
Treatment of Idiopathic Pulmonary Fibrosis with a New Antifibrotic Agent, Pirfenidone
1999
Asthma in Hispanics
2005
Changes in Clinical and Physiologic Variables Predict Survival in Idiopathic Pulmonary Fibrosis
2003
Prognostic Implications of Physiologic and Radiographic Changes in Idiopathic Interstitial Pneumonia
2003
Pharmacological Therapy for Idiopathic Pulmonary Fibrosis
1999
Idiopathic Pulmonary Fibrosis
1998
Pirfenidone Reduces Respiratory-related Hospitalizations in Idiopathic Pulmonary Fibrosis
2017
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Does Idiopathic Pulmonary Fibrosis Increase Lung Cancer Risk?
2000
Spirometric Reference Values from a Sample of the General U.S. Population
1999 Standout
Idiopathic Pulmonary Fibrosis
2000
Clinical, Radiologic, and Induced Sputum Features of Chronic Obstructive Pulmonary Disease in Nonsmokers
2002
Exposure to Commonly Prescribed Drugs and the Etiology of Cryptogenic Fibrosing Alveolitis
1998
Colchicine versus Prednisone in the Treatment of Idiopathic Pulmonary Fibrosis
1998
3d Transition Metals for C–H Activation
2018 Standout
Pulmonary rehabilitation for chronic obstructive pulmonary disease
2015 Standout
Idiopathic Pulmonary Fibrosis
2000
Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis
2004 Standout
The Clinical Use of the Multiple Sleep Latency Test
1992
Mechanisms of Pulmonary Fibrosis
2004
Hazardous air pollutants and asthma.
2002
Validation of self reported smoking by serum cotinine measurement in a community-based study
2002
Serial High Resolution CT Findings in Nonspecific Interstitial Pneumonia/Fibrosis
2000
Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2
2012 StandoutNobel
Neutralization of the CXC Chemokine, Macrophage Inflammatory Protein-2, Attenuates Bleomycin-Induced Pulmonary Fibrosis
1999
Idiopathic Pulmonary Fibrosis: Prevailing and Evolving Hypotheses about Its Pathogenesis and Implications for Therapy
2001 Standout
STAT‐3 contributes to pulmonary fibrosis through epithelial injury and fibroblast‐myofibroblast differentiation
2015
Osteopontin Is Associated with T Cells in Sarcoid Granulomas and Has T Cell Adhesive and Cytokine-Like Properties In Vitro
1999
Formaldehyde in the Indoor Environment
2010 Standout
Severity of Respiratory Syncytial Virus Bronchiolitis Is Affected by Cigarette Smoke Exposure and Atopy
2005
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
2019 Standout
IFN-gamma-inducible protein-10 attenuates bleomycin-induced pulmonary fibrosis via inhibition of angiogenesis.
1999
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
IFN-γ-Inducible Protein-10 Attenuates Bleomycin-Induced Pulmonary Fibrosis Via Inhibition of Angiogenesis
1999
Thalidomide Prevents Bleomycin-Induced Pulmonary Fibrosis in Mice
2007
Long-Term Effects of Budesonide or Nedocromil in Children with Asthma
2000
British Thoracic Society study of cryptogenic fibrosing alveolitis: current presentation and initial management. Fibrosing Alveolitis Subcommittee of the Research Committee of the British Thoracic Society
1997
IL-12 attenuates bleomycin-induced pulmonary fibrosis
2001
Idiopathic Pulmonary Fibrosis
2018 Standout
Mortality by Hispanic Status in the United States
1993 Standout
Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study
2005 Standout
SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials
2013 Standout
Ischemic heart disease mortality in Hispanics, American Indians, and non-Hispanic whites in New Mexico, 1958-1982.
1988
Works of David Coultas being referenced
Health effects of passive smoking bullet 8 : Passive smoking and risk of adult asthma and COPD: an update
1998
Health Care Utilization in Chronic Obstructive Pulmonary Disease
2000
Comparison of Self- and Spouse Reports of Snoring and Other Symptoms Associated with Sleep Apnea Syndrome
1990
Cigarette Yields of Tar and Nicotine and Markers of Exposure to Tobacco Smoke
1993
Role of Gastroesophageal Reflux Symptoms in Exacerbations of COPD
2006
Discrepancies between Self-reported and Validated Cigarette Smoking in a Community Survey of New Mexico Hispanics
1988
Occupational and Environmental Risk Factors for Idiopathic Pulmonary Fibrosis: A Multicenter Case-Control Study
2000
Undiagnosed airflow obstruction: prevalence and implications
2003
Spirometric Prediction Equations for Hispanic Children and Adults in New Mexico
1988
Patterns and Economic Burden of Hospitalizations and Exacerbations Among Patients Diagnosed with Idiopathic Pulmonary Fibrosis
2016
Respiratory Diseases and Cigarette Smoking in a Hispanic Population in New Mexico
1988
Corticosteroids and the Treatment of Idiopathic Pulmonary Fibrosis
1996
Respiratory and Irritant Health Effects of Ambient Volatile Organic Compounds
1993
The epidemiology of interstitial lung diseases.
1994
DIABETES, GALLBLADDER DISEASE, OBESITY, AND HYPERTENSION AMONG HISPANICS IN NEW MEXICO
1988
QUESTIONNAIRE ASSESSMENT OF LIFETIME AND RECENT EXPOSURE TO ENVIRONMENTAL TOBACCO SMOKE
1989
Prediction of Lung Function in Hispanics Using Local Ethnic-specific and External Non-ethnic-specific Prediction Equations
1993
Utilization in COPD
2000
Ethical Considerations in the Interpretation and Communication of Clinical Trial Results
2007
Healthcare resource utilization among patients diagnosed with idiopathic pulmonary fibrosis in the United States
2014
Idiopathic pulmonary fibrosis: survival in population based and hospital based cohorts
1998
An Official American Thoracic Society Public Policy Statement: Novel Risk Factors and the Global Burden of Chronic Obstructive Pulmonary Disease
2010
Salivary Cotinine Levels and Involuntary Tobacco Smoke Exposure in Children and Adults in New Mexico
1987
The Health Impact of Undiagnosed Airflow Obstruction in a National Sample of United States Adults
2001
Respiratory Diseases in Minorities of the United States
1994
OCCUPATIONAL LUNG CANCER
1992
Epidemiology of Idiopathic Pulmonary Fibrosis
1993
Altitude and Mortality from Chronic Obstructive Lung Disease in New Mexico
1984
Mortality rates from cryptogenic fibrosing alveolitis in seven countries.
1996
Accuracy of mortality data for interstitial lung diseases in New Mexico, USA.
1996